Challenges encountered in the implementation of bio-fluorescent particle counting systems as a routine microbial monitoring tool

Broadcast date

Wed, Oct 26, 2022

 

Presented by

    Allison Scott - MicronView
    Joanny Salvas - Pfizer
    Phil Villari - Merck & Co., Inc

 

Quick Description

In this webinar, potential challenges during the implementation of a bio-fluorescent particle counting system are discussed, sharing the perspective of a consortium of four industry-working groups on navigating these challenges.

Details

In this webinar, potential challenges during the implementation of a bio-fluorescent particle counting system are discussed, sharing the perspective of a consortium of four industry-working groups on navigating these challenges.

Bio-fluorescent particle counting technologies use the detection of intrinsic fluorescence to continuously enumerate bioburden levels in air or water samples. The reported unit is commonly referred to as an auto-fluorescence unit, which is not dependent upon growth like the traditional method. Examples of challenges include the perceived risk of regulatory inspectional observations and lack of acceptance, internal communication and acceptance, qualification strategy, and validation of a modern method that reports in a non-growth-based unit.

Information is shared on ways to navigate common challenges encountered during the implementation of new technologies, on a BFPC modern microbiological method, and an industry working group collaboration that offers support to the industry with the implementation and use of modern microbial methods.

Speakers

Allison Scott

MicronView

Joanny Salvas

Pfizer

Phil Villari

Merck & Co., Inc